Strong Balance SheetLow leverage and a high equity base reduce solvency risk and increase financial flexibility. This foundation supports sustained capital spending on hospitals and technology, enables strategic M&A or partnerships, and cushions the company against cyclical pressures over months.

Improved Cash GenerationRising free cash flow and a robust operating cash flow to net income ratio indicate the business can fund operations and reinvest internally. Strong cash conversion reduces reliance on external financing and supports long-term capex, working capital, and resilience to shocks.

Stable Margins And Rising Net ProfitConsistent gross and operating margins with improving net margin signal effective cost control and pricing/payer management. Sustained margin stability enhances long-term profitability, enabling reinvestment in care quality and capacity without eroding cash generation.

Bears Say

Inconsistent Revenue GrowthUneven top-line trends impair predictability of patient volumes and reimbursement receipts. This complicates capacity planning, resource allocation, and multi-period budgeting, potentially pressuring margins and cash flow reliability absent clearer secular demand drivers.

Declining EPS TrendMaterial negative EPS growth points to profit pressures that could reflect rising costs or episodic revenue weakness. If persistent, lower earnings per share limit retained earnings for reinvestment and reduce buffer for funding strategic initiatives or weathering reimbursement shocks.

Dependence On Insurance ReimbursementsHigh dependence on payer reimbursement exposes revenues and margins to regulatory changes and negotiated rate shifts. Reimbursement policy adjustments or payer negotiating leverage can have lasting impact on revenues and unit economics over multiple quarters.

RHK FAQ

What was RHON-KLINIKUM AG’s price range in the past 12 months?

RHON-KLINIKUM AG lowest stock price was €11.20 and its highest was €16.40 in the past 12 months.

What is RHON-KLINIKUM AG’s market cap?

RHON-KLINIKUM AG’s market cap is €876.89M.

When is RHON-KLINIKUM AG’s upcoming earnings report date?

RHON-KLINIKUM AG’s upcoming earnings report date is Mar 26, 2026 which is in 30 days.

How were RHON-KLINIKUM AG’s earnings last quarter?

RHON-KLINIKUM AG released its earnings results on Nov 06, 2025. The company reported €0.148 earnings per share for the quarter, beating the consensus estimate of N/A by €0.148.

Is RHON-KLINIKUM AG overvalued?

According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does RHON-KLINIKUM AG pay dividends?

RHON-KLINIKUM AG pays a Annually dividend of €0.1 which represents an annual dividend yield of 0.77%. See more information on RHON-KLINIKUM AG dividends here

What is RHON-KLINIKUM AG’s EPS estimate?

RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does RHON-KLINIKUM AG have?

RHON-KLINIKUM AG has 66,962,470 shares outstanding.

What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?

RHON-KLINIKUM AG reported an EPS of €0.148 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.826%.

Which hedge fund is a major shareholder of RHON-KLINIKUM AG?

Currently, no hedge funds are holding shares in DE:RHK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

RHON-KLINIKUM AG Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

2.94%

Trailing 12-Months

Asset Growth

1.20%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

RHON-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.